Return On Equity of Nascent Biotech Inc. from 30 Sep 2015 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nascent Biotech Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2015 to 30 Jun 2024.
  • Nascent Biotech Inc. Return On Equity for the quarter ending 30 Jun 2024 was 1030%, a 526% increase year-over-year.
  • Nascent Biotech Inc. annual Return On Equity for 2023 was 158%, a 58% decline from 2022.
  • Nascent Biotech Inc. annual Return On Equity for 2022 was 374%, a 677% increase from 2021.
  • Nascent Biotech Inc. annual Return On Equity for 2021 was 48%, a 34% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Nascent Biotech Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 1030% +866% +526% 01 Apr 2024 30 Jun 2024
Q1 2024 620% +408% +192% 01 Jan 2024 31 Mar 2024
Q4 2023 351% +120% +52% 01 Oct 2023 31 Dec 2023
Q3 2023 288% +154% +115% 01 Jul 2023 30 Sep 2023
Q2 2023 165% +18% +12% 01 Apr 2023 30 Jun 2023
Q1 2023 212% +149% +238% 01 Jan 2023 31 Mar 2023
Q4 2022 231% +276% 01 Oct 2022 31 Dec 2022
Q3 2022 134% +23% +20% 01 Jul 2022 30 Sep 2022
Q2 2022 147% +2.8% +1.9% 01 Apr 2022 30 Jun 2022
Q1 2022 63% -35% -36% 01 Jan 2022 31 Mar 2022
Q4 2021 -46% -322% -116% 01 Oct 2021 31 Dec 2021
Q3 2021 111% -155% -58% 01 Jul 2021 30 Sep 2021
Q2 2021 144% -117% -45% 01 Apr 2021 30 Jun 2021
Q1 2021 98% -207% -68% 01 Jan 2021 31 Mar 2021
Q4 2020 277% +93% +51% 01 Oct 2020 31 Dec 2020
Q3 2020 266% +67% +33% 01 Jul 2020 30 Sep 2020
Q2 2020 261% +19% +7.7% 01 Apr 2020 30 Jun 2020
Q1 2020 305% -18% -5.5% 01 Jan 2020 31 Mar 2020
Q4 2019 184% -381% -68% 01 Oct 2019 31 Dec 2019
Q3 2019 200% -5077% -96% 01 Jul 2019 30 Sep 2019
Q2 2019 242% +918% 01 Apr 2019 30 Jun 2019
Q1 2019 323% +688% 01 Jan 2019 31 Mar 2019
Q4 2018 565% +796% 01 Oct 2018 31 Dec 2018
Q3 2018 5277% +5506% 01 Jul 2018 30 Sep 2018
Q2 2018 -676% -696% -3499% 01 Apr 2018 30 Jun 2018
Q1 2018 -365% -610% -249% 01 Jan 2018 31 Mar 2018
Q4 2017 -232% +535% +70% 01 Oct 2017 31 Dec 2017
Q3 2017 -229% -11% -4.9% 01 Jul 2017 30 Sep 2017
Q2 2017 20% -255% -93% 01 Apr 2017 30 Jun 2017
Q1 2017 245% -53% -18% 01 Jan 2017 31 Mar 2017
Q4 2016 -766% -1046% -374% 01 Oct 2016 31 Dec 2016
Q3 2016 -219% -485% -182% 01 Jul 2016 30 Sep 2016
Q2 2016 275% 01 Apr 2016 30 Jun 2016
Q1 2016 298% 01 Jan 2016 31 Mar 2016
Q4 2015 280% 01 Oct 2015 31 Dec 2015
Q3 2015 266% 01 Jul 2015 30 Sep 2015

Nascent Biotech Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 158% -216% -58% 01 Apr 2023 31 Mar 2024
2022 374% +325% +677% 01 Apr 2022 31 Mar 2023
2021 48% -25% -34% 01 Apr 2021 31 Mar 2022
2020 73% -871% -92% 01 Apr 2020 31 Mar 2021
2019 944% +1169% 01 Apr 2019 31 Mar 2020
2018 -225% +254% +53% 01 Apr 2018 31 Mar 2019
2017 -479% -397% -487% 01 Apr 2017 31 Mar 2018
2016 -82% 01 Apr 2016 31 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.